Hillstream BioPharma and University of Massachusetts Chan Medical School Announce Research Collaboration using CRISPR and Computational Approaches to Advance The Hillstream Ferroptomic Atlas
Go back to Hillstream BioPharma and University of Massachusetts Chan Medical School Announce Research Collaboration using CRISPR and Computational Approaches to Advance The Hillstream Ferroptomic Atlas| (NASDAQ: HILS) | Delayed: 0.23 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.23 | 52 Week High | $ | |||
| Open | $0.23 | 52 Week Low | $ | |||
| Day High | $0.23 | P/E | N/A | |||
| Day Low | $0.23 | EPS | $ | |||
| Volume | 920 | |||||
